Aurinia has nabbed its first FDA approval with an OK for Lupkynis (voclosporin) to treat lupus nephritis, or kidney inflammation caused by systemic lupus erythematosus. And now it’ll look to its newly…

With the demand for cell and gene therapies mounting, CDMO Cognate BioServices is looking to swiftly expand its U.S. headquarters with two new facilities—and it’s not stopping there. Its dedicated…

As AstraZeneca nears European authorization for its highly anticipated COVID-19 vaccine, the drugmaker has notified officials that initial shipments will come in lighter than originally expected. Two German-language publications, Bild…

Five people have died after a fire broke out at Serum Institute of India’s home base in the western state of Pune, the company revealed Thursday, but the blaze, now under…

The COVID-19 pandemic has raised the profile of mRNA vaccines in a dramatic way in about a year. Looking forward, the technology holds more promise and could displace traditional shots…

Eli Lilly’s bamlanivimab was the first antibody drug the FDA authorized to treat COVID-19. Now, the Indianapolis pharma has data showing the therapy prevents symptomatic infections. The catch? The data…

Drug-pricing watchdogs haven’t been kind to next-generation multiple sclerosis treatments, even though their developers have been offering piles of evidence to show the treatments offer clear benefits to patients. Britain’s National…

The newly chosen Cannes Lions Health pharma and health and wellness jury chiefs will have their work cut out for them this summer. Thanks to the pandemic forcing the show’s cancellation in 2020, judges…